These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4593769)

  • 1. The effect of spironolactone on antipyrine metabolism in man.
    Huffman DH; Shoeman DW; Pentikäinen P; Azarnoff DL
    Pharmacology; 1973; 10(6):338-44. PubMed ID: 4593769
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of spironolactone on antipyrine metabolism in calves.
    Janus K; Suszycka J
    Res Vet Sci; 1996 Jul; 61(1):87-8. PubMed ID: 8819201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipyrine metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Life Sci; 1978 Dec; 23(25):2485-90. PubMed ID: 732536
    [No Abstract]   [Full Text] [Related]  

  • 6. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipyrine metabolite kinetics in rats: studies on dose and time dependence.
    Rhodes JC; Houston JB
    Biopharm Drug Dispos; 1983; 4(2):125-35. PubMed ID: 6411138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
    Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL
    Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
    Petruch F; Schüppel RV
    Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429
    [No Abstract]   [Full Text] [Related]  

  • 11. Temporal variations of antipyrine half-life in man.
    Vesell ES; Shively CA; Passananti GT
    Clin Pharmacol Ther; 1977 Dec; 22(6):843-52. PubMed ID: 923179
    [No Abstract]   [Full Text] [Related]  

  • 12. Haem biosynthesis and hydroxylation of phenazone during lead intoxication.
    Campbell BC; Meredith PA; Moore MR; Brodie MJ; Thompson GG; Goldberg A
    Biochem Soc Trans; 1976; 4(6):1088-9. PubMed ID: 1022564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of ranitidine on antipyrine metabolism (author's transl)].
    Staiger C; Simon B; de Vries J; Kather H; Walter E
    Z Gastroenterol; 1980 Dec; 18(12):601-4. PubMed ID: 6116365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the regulation of antipyrine and oxazepam metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine induction and hepatic vitamin D hydroxylation in man [proceedings].
    Brodie MJ; Davies DS; Dollery CT; Fraser HS; Hillyard CJ; MacIntyre I; Mucklow JE; Wilmana PF
    Br J Clin Pharmacol; 1979 Apr; 7(4):417P. PubMed ID: 444367
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole does not impair antipyrine clearance in humans.
    Blyden GT; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):225-6. PubMed ID: 3733272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolism of antipyrine in man].
    Pautet F; Barret R; Daudon M; Mathian B
    Pathol Biol (Paris); 1985 Sep; 33(7):777-80. PubMed ID: 3909077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.